azithromycin and cp-63,956 , new extended-half-life macrolides which reach high levels in tissue , exhibit in vitro antiamebic activity at 18 or 48 h of incubation at concentrations comparable to that of erythromycin and slightly higher than that of metronidazole .
C0052796
azithromycin
C0014806
erythromycin